Published in Oncogene on August 14, 2006
Targeting protein prenylation for cancer therapy. Nat Rev Cancer (2011) 2.60
Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth. Mol Cell Biol (2007) 1.32
A novel geranylgeranyl transferase inhibitor in combination with lovastatin inhibits proliferation and induces autophagy in STS-26T MPNST cells. J Pharmacol Exp Ther (2010) 0.96
(--)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells. Chem Res Toxicol (2011) 0.94
Regulation of cholesterol biosynthesis and cancer signaling. Curr Opin Pharmacol (2012) 0.91
Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-κB pathway and MMP-2 production by targeting RhoB activation. Br J Pharmacol (2011) 0.89
Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification. Br J Cancer (2009) 0.89
HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs. Cell Res (2011) 0.88
Pleiotropic functions of Rho GTPase signaling: a Trojan horse or Achilles' heel for breast cancer treatment? Curr Drug Targets (2010) 0.87
Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors. Nat Protoc (2011) 0.84
Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis. Mol Cancer (2010) 0.83
Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development. PLoS One (2013) 0.81
Activation of the RhoB signaling pathway by thyroid hormone receptor β in thyroid cancer cells. PLoS One (2014) 0.79
RhoB upregulation leads to either apoptosis or cytostasis through differential target selection. Endocr Relat Cancer (2015) 0.78
Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer. Br J Cancer (2008) 0.77
SiRNA Delivery with PEGylated Graphene Oxide Nanosheets for Combined Photothermal and Genetherapy for Pancreatic Cancer. Theranostics (2017) 0.75
Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells. Sci Rep (2017) 0.75
NSC126188, a piperazine alkyl derivative, induces apoptosis via upregulation of RhoB in HeLa cells. Invest New Drugs (2010) 0.75
Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem (2001) 3.27
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther (2001) 2.83
Retracted Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science (2001) 2.52
The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. J Biol Chem (1997) 1.98
Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum Gene Ther (2000) 1.97
Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol (1999) 1.80
Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies. Oncogene (2000) 1.80
Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene (1999) 1.78
Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J Biol Chem (1995) 1.75
Effects of multivitamin and mineral supplementation on adiposity, energy expenditure and lipid profiles in obese Chinese women. Int J Obes (Lond) (2010) 1.70
Toward proteomimetics: terphenyl derivatives as structural and functional mimics of extended regions of an alpha-helix. J Am Chem Soc (2001) 1.67
Peptide and protein recognition by designed molecules. Chem Rev (2000) 1.61
The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. Virology (1998) 1.61
Active case finding: understanding the burden of tuberculosis in rural South Africa. Int J Tuberc Lung Dis (2001) 1.58
Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol (1999) 1.55
Medical professional involvement in smartphone 'apps' in dermatology. Br J Dermatol (2012) 1.46
Relationship between vitamin D status, body composition and physical exercise of adolescent girls in Beijing. Osteoporos Int (2008) 1.45
The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis. Mol Cell Biol (2000) 1.39
PKR, apoptosis and cancer. Int J Biochem Cell Biol (1999) 1.37
Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart (2000) 1.37
FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer (1993) 1.37
Bactericidal Activity of TiO2 Photocatalyst in Aqueous Media: Toward a Solar-Assisted Water Disinfection System. Environ Sci Technol (1994) 1.35
The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner. J Biol Chem (1997) 1.35
Retracted Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat Cell Biol (2000) 1.34
Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor. J Biol Chem (1995) 1.33
Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J (1999) 1.30
Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles. J Virol (1992) 1.28
Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J Biol Chem (2000) 1.27
Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene (1999) 1.23
Homologous cellular proteins associated with simian virus 40 small T antigen and polyomavirus medium T antigen. J Virol (1988) 1.21
Comparison of QCT-derived and DXA-derived areal bone mineral density and T scores. Osteoporos Int (2008) 1.20
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane. Cell Death Differ (2010) 1.20
Structure and mutagenesis of the Dbl homology domain. Nat Struct Biol (1998) 1.18
Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion. Cancer Res (1995) 1.18
Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice. Nat Biotechnol (2000) 1.18
Risks for impaired cerebral autoregulation during cardiopulmonary bypass and postoperative stroke. Br J Anaesth (2012) 1.18
Autoinhibition mechanism of proto-Dbl. Mol Cell Biol (2001) 1.18
Chloramphenicol, gentamicin, and ciprofloxacin against murine scrub typhus. Antimicrob Agents Chemother (1988) 1.18
p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA. Mol Cell Biol (1998) 1.18
A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Oncogene (2007) 1.17
Deprivation and hospital admission for infectious intestinal diseases. Lancet (1999) 1.15
Mutational analysis of simian virus 40 small-t antigen. J Virol (1990) 1.13
v-Abl activates c-myc transcription through the E2F site. Mol Cell Biol (1995) 1.13
Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene (1989) 1.12
The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts. Cancer Res (1996) 1.11
Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol Biol Cell (2000) 1.11
GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. Cancer Res (1997) 1.11
RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem (2000) 1.10
Tyrosine phosphorylation of paxillin/pp125FAK and microvascular endothelial barrier function. Am J Physiol (1998) 1.10
The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells. J Biol Chem (2001) 1.10
Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway. J Immunol (2000) 1.10
Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes. Cancer Res (1998) 1.09
Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. Oncogene (1996) 1.09
Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol Ther (1990) 1.08
Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s). J Biol Chem (1999) 1.08
Risk factors for preeclampsia in twin pregnancies: a population-based cohort study. Obstet Gynecol (1995) 1.08
A multi-country Salmonella Enteritidis phage type 14b outbreak associated with eggs from a German producer: 'near real-time' application of whole genome sequencing and food chain investigations, United Kingdom, May to September 2014. Euro Surveill (2015) 1.07
An in vivo comparison of hip structure analysis (HSA) with measurements obtained by QCT. Osteoporos Int (2011) 1.07
Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation. J Biol Chem (1996) 1.07
FKBP-12 recognition is dispensable for signal generation by type I transforming growth factor-beta receptors. J Biol Chem (1996) 1.06
Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26 GeV. Phys Rev Lett (2013) 1.05
Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation. Oncogene (2012) 1.05
Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I. J Med Chem (1999) 1.04
Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene (2000) 1.02
ATP induces a conformational change in lipid-bound cytochrome c. J Biol Chem (2001) 1.02
E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Cell Growth Differ (1998) 1.02
Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on ras in human hepatic stellate cells. Hepatology (2000) 1.01